Related Experiment Video
Updated: Jul 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Which general intensive care unit patients can benefit from placement of the pulmonary artery catheter?
1Department of Anesthesiology & Critical Care Medicine, Lariboisière University Hospital, Paris, France. dpayen1234@aol.com
Abstract:
From the report by Connors and coworkers in 1996 until now, much effort has been directed at demonstrating the safety and/or effectiveness of strategies based on pulmonary artery catheter (PAC) data. Although studies have failed to demonstrate a clear benefit of PAC use, neither have any corroborated the initial report of PAC-induced mortality. With this in mind, it is important to clarify the indications for PAC, taking into account the development of new technologies to measure cardiac output and stroke volume. The present review focuses on safety and effectiveness data, with a special focus on reasonable indications for PAC use in the intensive care unit. The PAC has evolved since its initial presentation, and it now offers numerous parameters in addition to cardiac output and pressure measurement, such as mixed oxygen saturation and right ventricular ejection fraction. Because many techniques may be used to measure cardiac output, the indications for PAC use have become founded on other parameters that are useful in more specific situations, essentially involving the right circulation.
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization III: Left Heart Catheterization
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
